A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: A new strategy for heart failure diagnostics and therapeutics

European Journal of Heart Failure

Volumn 18, Issue 2, 2016, Pages 169-178

  Ruiz Esparza, Guillermo U ^a,b   Segura Ibarra, Victor ^a,b   Cordero Reyes, Andrea M ^c   Youker, Keith A ^c   Serda, Rita E ^d   Cruz Solbes, Ana S ^c   Amione Guerra, Javier ^c   Yokoi, Kenji ^a   Kirui, Dickson K ^a   Cara, Francisca E ^a   Paez Mayorga, Jesus ^b   Flores Arredondo, Jose H ^d   Guerrero Beltrán, Carlos E ^b   Garcia Rivas, Gerardo ^b   Ferrari, Mauro ^a,e   Blanco, Elvin ^a   Torre Amione, Guillermo ^b,c  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^c HOUSTON METHODIST HOSPITAL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cardiomyopathy; Heart failure; Nanoconstructs; Nanomedicine; Nanoparticles; Nanotechnology

Indexed keywords

LIPOCORTIN 5; MESOPOROUS SILICON VECTOR; NANOPARTICLE; SILICON; UNCLASSIFIED DRUG; BIOMATERIAL; NANOMATERIAL; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTERY MUSCLE; ARTICLE; CARDIOVASCULAR CELL; CELL CYCLE; CELL DEATH; CELL LINE; CELL NUCLEUS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY; CYTOTOXICITY; ENDOTHELIUM CELL; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SMOOTH MUSCLE FIBER; TIME-LAPSE VIDEO MICROSCOPY; VASCULAR ENDOTHELIUM; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; DISEASE MODEL; HEART; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BIOCOMPATIBLE MATERIALS; DISEASE MODELS, ANIMAL; HEART; HEART FAILURE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; MYOCYTES, CARDIAC; NANOSTRUCTURES; POLYMERS; SILICON;

EID: 84958121453     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.463     Document Type: Article

References (41)

1. Miller LW,. Limitations of current medical therapies for the treatment of heart failure. Rev Cardiovasc Med 2003; 4 (Suppl 2): S21-S29.
2. Giacca M, Baker AH,. Heartening results: the CUPID gene therapy trial for heart failure. Mol Ther 2011; 19: 1181-1182.
3. Matsumura Y, Maeda H,. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46: 6387-6392.
4. Dvir T, Bauer M, Schroeder A, Tsui JH, Anderson DG, Langer R, Liao R, Kohane DS,. Nanoparticles targeting the infarcted heart. Nano Lett 2011; 11: 4411-4414.
5. Ruiz-Esparza GU, Flores-Arredondo JH, Segura-Ibarra V, Torre-Amione G, Ferrari M, Blanco E, Serda RE,. The physiology of cardiovascular disease and innovative liposomal platforms for therapy. IntJ Nanomed 2013; 8: 629-640.
6. Taimeh Z, Loughran J, Birks EJ, Bolli R,. Vascular endothelial growth factor in heart failure. Nat Rev Cardiol 2013; 10: 519-530.
7. Liesmaa I, Kuoppala A, Shiota N, Kokkonen JO, Kostner K, Mayranpaa M, Kovanen PT, Lindstedt KA,. Increased expression of bradykinin type-1 receptors in endothelium of intramyocardial coronary vessels in human failing hearts. Am J Physiol Heart Circ Physiol 2005; 288: H2317-H2322.
8. Giordano FJ,. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115: 500-508.
9. Torre-Amione G., Immune activation in chronic heart failure. Am J Cardiol 2005; 95: 3C-8C.
10. Tasciotti E, Liu X, Bhavane R, Plant K, Leonard AD, Price BK, Cheng MM, Decuzzi P, Tour JM, Robertson F, Ferrari M,. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 2008; 3: 151-157.
11. Blanco E, Sangai T, Hsiao A, Ferrati S, Bai L, Liu X, Meric-Bernstam F, Ferrari M,. Multistage delivery of chemotherapeutic nanoparticles for breast cancer treatment. Cancer Lett 2013; 334: 245-252.
12. Silva-Platas C, Garcia N, Fernandez-Sada E, Davila D, Hernandez-Brenes C, Rodriguez D, Garcia-Rivas G,. Cardiotoxicity of acetogenins from Persea americana occurs through the mitochondrial permeability transition pore and caspase-dependent apoptosis pathways. J Bioenerg Biomembr 2012; 44: 461-471.
13. Oestreicher EM, Martinez-Vasquez D, Stone JR, Jonasson L, Roubsanthisuk W, Mukasa K, Adler GK,. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury. Circulation 2003; 108: 2517-2523.
14. Garcia-Rivas G, Youker KA, Orrego C, Flores-Arredondo J, Guerrero-Beltran CE, Cordero-Reyes A, Gutierrez-Uribe JA, Garcia M, Serna-Saldivar SO, Torre-Amione G,. Standardized extracts from black bean coats (phaseolus vulgaris l.) prevent adverse cardiac remodeling in a murine model of non-ischemic cardiomyopathy. RSC Advances 2015; 5: 90858-90865.
15. Godin B, Chiappini C, Srinivasan S, Alexander JF, Yokoi K, Ferrari M, Decuzzi P, Liu X,. Discoidal porous silicon particles: Fabrication and biodistribution in breast cancer bearing mice. Adv Funct Mater 2012; 22: 4225-4235.
16. van de Ven AL, Kim P, Haley O, Fakhoury JR, Adriani G, Schmulen J, Moloney P, Hussain F, Ferrari M, Liu X, Yun SH, Decuzzi P,. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release 2012; 158: 148-155.
17. Decuzzi P, Godin B, Tanaka T, Lee SY, Chiappini C, Liu X, Ferrari M,. Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release 2010; 141: 320-327.
18. Decuzzi P, Ferrari M,. The receptor-mediated endocytosis of nonspherical particles. Biophys J 2008; 94: 3790-3797.
19. Shen J, Xu R, Mai J, Kim HC, Guo X, Qin G, Yang Y, Wolfram J, Mu C, Xia X, Gu J, Liu X, Mao ZW, Ferrari M, Shen H,. High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. ACS Nano 2013; 7: 9867-9880.
20. Serda RE, Gu J, Burks JK, Ferrari K, Ferrari C, Ferrari M,. Quantitative mechanics of endothelial phagocytosis of silicon microparticles. Cytometry A 2009; 75A: 752-760.
21. Serda RE, Ferrati S, Godin B, Tasciotti E, Liu XW, Ferrari M,. Mitotic trafficking of silicon microparticles. Nanoscale 2009; 1: 250-259.
22. Ferrati S, Serda RE, Bean A, Ferrari M,. Intracellular trafficking of nano-carriers. In Nemb2010: Proceedings of the Asme First Global Congress on Nanoengineering for Medicine and Biology-2010. The American Society of Mechanical Engineers Digital Collection. Houston Texas, USA. 2010:105-107.
23. Ferrati S, Mack A, Chiappini C, Liu XW, Bean AJ, Ferrari M, Serda RE,. Intracellular trafficking of silicon particles and logic-embedded vectors. Nanoscale 2010; 2: 1512-1520.
24. Serda RE, Gu J, Bhavane RC, Liu X, Chiappini C, Decuzzi P, Ferrari M,. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 2009; 30: 2440-2448.
25. James TN, Terasaki F, Pavlovich ER, Vikhert AM,. Apoptosis and pleomorphic micromitochondriosis in the sinus nodes surgically excised from five patients with the long qt syndrome. Jo Lab Clin Med 1993; 122: 309-323.
26. Blaes N, Crouzet B, Bourdillon MC, Boissel JP,. Comparative phagocytosis in culture of aortic smooth muscle cells and fibroblasts from rat. Proc Soc Exp Biol Med 1982; 170: 453-458.
27. Gao C, Xie R, Li W, Zhou J, Liu S, Cao F, Liu Y, Ma R, Si Y, Liu Y, Bi Y, Gilbert GE, Shi J,. Endothelial cell phagocytosis of senescent neutrophils decreases procoagulant activity. Thromb Haemos 2013; 109: 1079-1090.
28. Babaev VR, Popkova VM, Antonov AS, Repin VS,. [ Quantitative evaluation of the phagocytic activity of endothelial cells in culture ]. Biull Eksp Biol Med 1986; 101: 728-730 (in Russian).
29. Privalova LI, Katsnelson BA, Osipenko AB, Yushkov BN, Babushkina LG,. Response of a phagocyte cell system to products of macrophage breakdown as a probable mechanism of alveolar phagocytosis adaptation to deposition of particles of different cyto-toxicity. Environ Health Persp 1980; 35: 205-218.
30. Proffitt RT, Williams LE, Presant CA, Tin GW, Uliana JA, Gamble RC, Baldeschwieler JD,. Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles. Science 1983; 220: 502-505.
31. Harrison RE, Bucci C, Vieira OV, Schroer TA, Grinstein S,. Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: Role of rab7 and rilp. Mol Cell Biol 2003; 23: 6494-6506.
32. Ferrati S, Shamsudeen S, Summers HD, Rees P, Abbey JV, Schmulen J, Liu X, Wong ST, Bean AJ, Ferrari M, Serda RE,. Inter-endothelial transport of microvectors using cellular shuttles and tunneling nanotubes. Small 2012; 8: 3151-3160.
33. Serda RE, Gu J, Burks JK, Ferrari K, Ferrari C, Ferrari M,. Quantitative mechanics of endothelial phagocytosis of silicon microparticles. Cytometry A 2009; 75: 752-760
34. Cuddihy AR, O'Connell MJ,. Cell-cycle responses to DNA damage in g2. Int Rev Cytol. 2003; 222: 99-140.
35. Martinez JO, Parodi A, Liu X, Kolonin MG, Ferrari M, Tasciotti E,. Evaluation of cell function upon nanovector internalization. Small 2013; 9: 1696-1702.
36. Martinez JO, Boada C, Yazdi IK, Evangelopoulos M, Brown BS, Liu X, Ferrari M, Tasciotti E,. Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors. Small 2013; 9: 1722-1733.
37. Shen J, Xu R, Mai J, Kim H-C, Guo X, Qin G, Yang Y, Wolfram J, Mu C, Xia X, Gu J, Liu X, Mao Z-W, Ferrari M, Shen H,. High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. ACS Nano 2013; 7: 9867-9880.
38. Fischer D, Rossa S, Landmesser U, Spiekermann S, Engberding N, Hornig B, Drexler H,. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 2005; 26: 65-69.
39. Hastings CL, Roche ET, Ruiz-Hernandez E, Schenke-Layland K, Walsh CJ, Duffy GP,. Drug and cell delivery for cardiac regeneration. Adv Drug Deliv Rev 2015; 84: 85-106.
40. Kadam RS, Bourne DW, Kompella UB,. Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: Contribution of reduced clearance. Drug Metab Dispos 2012; 40: 1380-1388.
41. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM,. Angiotensin ii causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 2006; 103: 17985-17990.